Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
Kinco Automation (Shanghai) Co.,Ltd
688160
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
TENX Tenax Therapeutics
- 6.5000
- +0.0500+0.78%
Close Jan 22 16:00 ET
- 6.4500
- -0.0500-0.77%
Post 16:26 ET
22.16MMarket Cap-0.50P/E (TTM)
6.5901High6.4600Low9.81KVolume6.5000Open6.4500Pre Close64.00KTurnover0.43%Turnover RatioLossP/E (Static)3.41MShares21.459952wk High0.23P/B14.90MFloat Cap2.770052wk Low--Dividend TTM2.29MShs Float21599978.4000Historical High--Div YieldTTM2.02%Amplitude2.7700Historical Low6.5250Avg Price1Lot Size
About Tenax Therapeutics Company
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.
Company Profile
SymbolTENX
Company NameTenax Therapeutics
Listing DateJan 15, 2010
Founded1967
CEOMr. Christopher T. Giordano
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address101 Glen Lennox Drive,Suite 300
CityChapel Hill
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27517
Phone1-919-855-2100
Websitehttp://www.tenaxthera.com
Company Executives
- Name
- Position
- Salary
- Christopher T. Giordano
- Director, President and Chief Executive Officer
- 644.77K
- Thomas A. McGauley
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Stuart Rich, M.D.
- Director and Chief Medical Officer
- 481.22K
- Gerald T. Proehl
- Chairman of the Board
- 88.50K
- Robyn M Hunter
- Independent Director
- 65.00K
- Dr. Declan Doogan, M.D.
- Independent Director
- 48.50K
- Dr. Michael Harvey Davidson, M.D.
- Independent Director
- 57.50K
- Dr. June S. Almenoff, F.A.C.P.,M.D.,PhD
- Independent Director
- 59.50K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace